More than 15 million people in the United States have at least one of 105 autoimmune diseases, according to a recent study published in The Journal of Clinical Investigation . Women are twice as likely as men to be diagnosed. However, more than 76% of autoimmune patients receive at least one misdiagnosis. This is especially true for rheumatic disease patients with conditions such as rheumatoid arthritis (RA)—approximately 20% of patients originally diagnosed with RA are misdiagnosed, according to a separate study .

In this interview, Veena Joy, the U.S. autoimmunity lead for medical and scientific affairs at Thermo Fisher Scientific, explains why these delays are happening, where gender bias fits into the equation and shares why current research has her feeling hopeful.

This intervie

See Full Page